Patent AT-E401343-T1: [Translated] TOLEROGENIC PEPTIDES
Description
There is provided a tolerogenic human peptide, capable of binding to an MHC class I or II molecule without further antigen processing, for use in the treatment and/or prevention of multiple sclerosis, which peptide is selected from the following myelin basic protein (MBP) peptides: 83-99 and 131- 145.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the complete Patent AT-E401343-T1: [Translated] TOLEROGENIC PEPTIDES on the official website. |
https://pubchem.ncbi.nlm.nih.gov/patent/AT-E401343-T1 |
Tags
- patent
- chemistry
- research
- innovation
- pubchem